Catecholamines Enhance Dihydrolipoamide Dehydrogenase Inactivation by the Copper Fenton System. Enzyme Protection by Copper Chelators

References

• Correa J. Gutierrez, Stoppani A. O.M. Inactivation of lipoamide dehydrogenaseby cobalt(II) and iron(II) Fenton systems: effect of metal chelators, thiol com pounds and adenine nucleotides. Free Radical Research Communications 1993; 19: 303–314
   PubMed Web of Science ®Google Scholar
• Correa J. Gutierrez, Stoppani A. O.M. Inactivation of heart lipoamide dehydrogenase by copper Fenton systems. Effect of thiol compounds and metal chelators. Free Radical Research 1995; 22: 239–250
   PubMedGoogle Scholar
• Rao G. S. Release of 2-thiobarbituric acid reactive products from glutamate, deoxyuridine or DNA during autoxidation of dopamine in the presence of copper ions. Pharmacology and Toxicology 1991; 69: 169466
   Google Scholar
• Ryan T. P., Miller D. M., Aust S. D. The role of metals in the enzymatic and nonenzymatic oxidation of epinephrine. Journal of Biochemical Toxicology 1993; 8: 33–39
   PubMedGoogle Scholar
• Mattammal M. B., Strong R., White E., Hsu F. Characterization of peroxidative oxidation products of dopamine by mass spectrometry. Journal of Chromatography B 1994; 658: 21–30
   PubMedGoogle Scholar
• Herlinger E., Jameson R. F., Linert W. Spontaneous autoxidation of dopamine. Journal of Chemistry Society Perkin Transaction 1995; 2: 259–263
   Google Scholar
• Noble P. G., Antel J. P., Yong V. W. Astrocytes and catalase prevent the toxicity of catecholamines to oligodendrocytes. Brain Research 1994; 633: 83–90
   PubMedGoogle Scholar
• Linderson Y., Baez S., Segura-Aguilar J. The protective effect of superoxide dismutase and catalase against formation of reactive oxygen species during reduction of cyclized norepinephrine ortho-quinone by DT-diaphorase. Biochimica et Biophysica Acta 1994; 1200: 197–204
   PubMed Web of Science ®Google Scholar
• Spencer J. P.E., Jenner A., Aruoma O. I., Evans P. J., Kaur H., Dexter D. T., Jenner P., Lees A. J., Marsden D. C., Halliwell B. Intense oxidative DNA damage pro moted by L-DOPA and its metabolites. Implications for neurodegenerative disease. FEBS Letters 1994; 353: 246–250
   PubMed Web of Science ®Google Scholar
• Basma A. N., Morris E. J., Nicklas W. J., Geller H. M. L-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation. Journal of Neurochemistry 1995; 64: 825–832
   PubMed Web of Science ®Google Scholar
• Chiueh C. C., Miyake H., Peng M.-T. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MFTP-induced parkinsonism. Advances in Neurology. Raven Press, Ltd., New York 1993; 60: 251–257
   Google Scholar
• Przedborski S., Jackson-Lewis V., Muthane U., Jiang U., Ferreira M., Naini A. B., Fahn S. Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity. Annals of Neurology 1993; 34: 715–723
   PubMed Web of Science ®Google Scholar
• Pardo B., Mena M. A., Garcia de Yebenes J. L-DOPA inhibits complex IV of the electron transport chain in catecholamine-rich human neuroblastoma NB69 cells. Journal of Neurochemistry 1995; 64: 576–582
   PubMed Web of Science ®Google Scholar
• Ben-Shachar D., Zuk R., Glinka Y. Dopamine neurotoxicity: inhibition of mitochondrial respiration. Journal of Neurochemistry 1995; 64: 718–723
   PubMed Web of Science ®Google Scholar
• Jewett S. L., Eddy L. J., Hochstein P. Is the autoxidation of catecholamines involved in ischemia-reperfusion injury?. Free Radical Biology and Medicine 1989; 6: 185–188
   PubMedGoogle Scholar
• Chevion M., Jiang Y., Har-EI R., Berenshtein E., Uretzky G., Kitrossky N. Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury. Proceedings of the National Academy of Sciences of the United States of America 1993; 90: 1102–1106
   PubMed Web of Science ®Google Scholar
• Obata T., Hosokawa H., Yamanaka Y. In vivo monitoring of norepinephrine and *OH generation on myocardial ischemic injury by dialysis technique. American Journal of Physiology 1994; 266: H903–H908
   PubMed Web of Science ®Google Scholar
• Gutteridge J. M.C. Ferrous-salt-promoted damage to deoxyribose and benzoate. Biochemical Journal 1987; 243: 709–714
   PubMed Web of Science ®Google Scholar
• Rowley D. A., Halliwell B. Formation of hydroxyl radicals from NADH and NADPH in the presence of copper salts. Journal of Inorganic Biochemistry 1985; 23: 103–108
   PubMed Web of Science ®Google Scholar
• Ondetti M. A. From peptides to peptidases: a chronicle of drug discovery. Annual Review of Pharmacology and Toxicology 1994; 34: 1–16
   PubMedGoogle Scholar
• Solen G. Radioprotective effect of N-acetylcysteine in vitro using the induction of DNA breaks and end-point. international Journal Radiation Biology 1993; 64: 359–366
   PubMed Web of Science ®Google Scholar
• Puppo A., Cecchini R., Aruoma O. I., Bolli R., Halliwell B. Scavenging of hypochlorous acid and of myoglobin-derived oxidants by the cardioprotective agent mercaptopropionylglycine. Free Radical Research Communications 1990; 10: 371–381
   PubMed Web of Science ®Google Scholar
• Scheer B., Zimmer G. Dihydrolipoic acid pre vents hypoxic/reoxygenation and peroxidative damage in rat heart mitochondria. Archives of Biochemistry and Biophysics 1993; 302: 385–390
   PubMedGoogle Scholar
• Suzuki Y. J., Tsuchiya M., Packer L. Antioxidant activities of dihydrolipoic acid and its structural homologues. Free Radical Research Communications 1993; 18: 115–122
   PubMed Web of Science ®Google Scholar
• Lmstad R. A. Copper catalyzed oxidation of ascorbate (vitamin C). Inhibitory effect of catalase, superoxide dismutase, serum proteins (ceruloplasmin, albumin, apotransferrin) and amino acids. International Journal of Biochemistry 1987; 19: 309–313
   PubMedGoogle Scholar
• Kukreja R. C., Loesser K. E., Kearns A. A., Naseem S. A., Hess M. L. Protective effects of histidine during ischemia-reperfusion in isolated perfused rat hearts. American Journal of Physiology 1993; 264: H1370–GH1381
   PubMedGoogle Scholar
• van Maanen J.M.S., Verkerk U. H., Broersen J., Lafleur M. V.M., de Vries J., Retél J., Pinedo H. M. Semi-quinone formation from the catechol and orthoquinone metabolites of the antitumor agent VP-16–213. Free Radical Research Communications 1988; 4: 371–384
   PubMed Web of Science ®Google Scholar
• van der Merwe M.J., Jenkins K., Theron E., van der Walt B.J. Interaction of the dicatecholsrooperol and nordihydroguaiaretic acid with oxidative systems in the human blood. Biochemical Pharmacology 1993; 45: 303–311
   PubMedGoogle Scholar
• Cohen G., Heikkila R. E. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. Journal of Biological Chemistry 1974; 249: 2447–2452
   PubMed Web of Science ®Google Scholar
• Matthews R. G., Williams C. H. Identification of the thiol residues involved in modifications of pig heart lipoamide dehydrogenase by cupric ion and byiodoacetamide. Biochimica et Biophysica Acta 1974; 370: 39–48
   PubMedGoogle Scholar
• Ozawa T., Ueda J., Hanaki A. Copper(II)-albumin complex can activate hydrogen peroxide in the presence of biological c; first ESR evidence for the formation of hydroxyl radical. Biochemical and Molecular Biology International 1993; 29: 247–253
   PubMedGoogle Scholar
• Ueda J. I., Shimazu Y., Ozawa T. Reactions of copper(II)-oligopeptide complexes with hydrogen per oxide: effects of biological reductants. Free Radical Biology and Medicine 1995; 18: 929–933
   PubMed Web of Science ®Google Scholar
• Kable E. P.W., Parsons P. G. Potency, selectivity and cell cycle dependence of catechols in human tumour cells. in nitro, Biochemical Pharmacology 1988; 37: 1711–1715
   PubMed Web of Science ®Google Scholar
• Misik V., Mak I. T., Stafford R. E., Weglicki W. B. Reactions of captopril and epicaptopril with transition metal ions and hydroxyl radicals: an EPR spectroscopy study. Free Radical Biology and Medicine 1993; 15: 611–619
   PubMed Web of Science ®Google Scholar
• Andreoli S. P. Captopril scavenges hydrogen per oxide and reduces, but does not eliminate, oxidant-induced cell injury. American Journal of Physiology 1993; 264: F120–F127
   PubMedGoogle Scholar
• Chopra K., Singh M., Kaul N., Ganguly N. K. Oxygen free radicals and protective effect of captopril on myocardial infarct size. Archives Internationales de Pharmacodynamie et de Thérapie 1993; 322: 55–65
   PubMedGoogle Scholar
• Sun J.-Z., Kaur H., Halliwell B., Li X.-Y., Bolli R. Use of aromatic hydroxylation of phenylalanine to mea sure production of hydroxyl radicals after myocardial ischemia in vivo. Direct evidence for a pathogenetic role of the hydroxyl radical in myocardial stunning. Circulation Research 1993; 73: 534–549
   PubMed Web of Science ®Google Scholar
• Mira M. L., Silva M. M., Queirzo M. J., Manso C. F. Angiotensin converting enzyme inhibitors as oxygen free radicals scavengers. Free Radical Research Communications 1993; 19: 173–181
   PubMed Web of Science ®Google Scholar
• Adams J. D., Odunze I. N. Oxygen free radicals and Parkinson's disease. Free Radical Biology and Medicine 1991; 10: 161–169
   PubMed Web of Science ®Google Scholar